CCG-203971 is a Second-Generation RhoA/MRTF-A Inhibitor with Antifibrotic Effect
Metastasis is the major driver in cancer-related deaths. Metastases involve dysregulation of numerous cellular processes. Importantly, blockade of RhoC prevents cellular invasion in breast and prostate cancer models. Especially, RhoA…